Applied Filters
831(b)s: under the microscope
831(b) captive insurance companies have been under the microscope for six months as the Internal Revenue Service subjects them to the greatest possible scrutiny. What’s behind this sudden concern? US Captive investigates.
Changes in healthcare bring captive solutions to the forefront
Ed Marley, CFO of Mutual Insurance Company of Arizona and treasurer of MICA Specialty, and Julie Ritzman, vice president of risk management at Mutual Insurance Company of Arizona, explain how the shifting healthcare landscape has led to physician-owned practices reevaluating the delivery and structure of medical professional liability insurance.
Captives expansion drives demand for experienced directors
Andrew Barile, CEO of Andrew Barile Consulting, explains how the value of taking on an insurance industry expert at a board level is often overlooked among captive owners.
Group captives part 2: sharing losses
To convince large members to join with smaller members, and vice versa, the prospective premium rating system needs to take account of loss experience. Hugh Rosenbaum, captive consultant and retired principal of Willis Towers Watson, explains the principle of proportional parity.
Group captives: the inner workings and obstacles
In the first of a series of articles for Captive International captive consultant and retired principal of WTW Hugh Rosenbaum explores the mechanics of setting up a group captive and why it might be a good option for insurance buyers.
Innovation in reserving methodology
The Risk Authority (TRA) is an innovative healthcare risk consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivalled industry expertise and quantifiable results.
Protected cell companies and their future
Cell captives are proving an increasingly popular option for parents. In this article Alain Dufraisse of Aon Insurance Managers, Gibraltar, details the territory’s offering in the space.
Cell innovations
Cayman has further developed its capabilities in the cell captive space through the introduction of the portfolio insurance company, as the jurisdiction looks to stay on the cutting edge of captive developments.
Exploring cells in healthcare
Cayman captives are increasingly converting to segregated portfolio companies, particularly in the healthcare sector and as a result of US healthcare reform. Paul Scrivener and Stefanie Suckoo at Solomon Harris review the conversion process and the options available to captives.
ACOs: an uncertain opportunity
Seismic changes in the US healthcare landscape will create both challenges and opportunities for those captives willing to grasp the nettle. US Captive explores the liability challenge as captives begin to work with emerging ACOs.
